1Abou E1 Hassan, M.A., Mastenbroek, D.C., Gerritsen, W.R., Giaccone, G., Kruyt, EA., 2004. Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL. Br. J. Cancer 91. 171--177.
4Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., Croce, C.M., 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101, 2999--3004.
5Cimmino, A., Calin, G.A., Fabbri, M., Iorio, M.V., Ferracin, M., Shimizu, M., Wojcik, S.E., Aqeilan, R.I., Zupo, S., Dono, M., Rassenti, L., Alder, H., Volinia, S., Liu, C.G., Kipps, T.J., Negrini, M., Croce, C.M., 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 102. 13944-13949.
6Danial, N.N., 2007. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin. Cancer Res. 13, 7254--7263.
7Degterev, A., Boyce, M., Yuan, J., 2003. A decade of caspases. Oncogene 22, 8543--8567.
8Hanahan, D., Weinberg, R.A., 2000. The hallmarks of cancer. Cell 100, 57--70.
9Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K., Kawahara, K., Toki, K., Kawakami, K., Nishiyama, K., Tsujimoto, G., Nakagawa, M., Seki, N., 2009. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 125. 345--352.
10Iorio, M.V., Ferracin, M., Liu, C.G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Menard, S., Palazzo, J.E, Rosenberg, A., Musiani, E, Volinia, S., Nenci, I., Calin, G.A., Querzoli, E, Negrini, M., Croce, C.M., 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065--7070.
2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007[ J]. CA Cancer J Clin, 2007,57( 1 ) :43-66.
3CalinG A, Croce C M. MicroRNA signatures in human cancers [ J ]. Nat Rev Cancer, 2006,6 ( 11 ) : 857-866.
4Bao B, Rodriguez-Melendez R, Wijeratne S S, et al. Bi- otin regulates the expression of holocarboxylasesynthetase in the miR-539 pathway in HEK-295 cells [ J ]. J Nutr, 2010,140 ( 9 ) : 1546-1551.
5Gu L, Sun W. miR-539 inhibits thyroid cancer cell migra- tion and invasion by directly targeting CARMA1 [ J ]. Bio- chemBiophys Res Commun, 2015,464(4) :1128-1133.
6Muthusamy S, DeMartino A M, Watson L J, et al. Mi- croRNA-539 is up-regulated in failing heart, and suppres- ses O-GleNAcase expression[J]. J Biol Chem, 2014,289 (43) :29665-29676.
7Wang K, Long B, Zhou L Y, et al. CARL IncRNA in- hihits anoxia-indueed mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation[ J]. Nat Commun, 2014,5:3596.
8Hagan J P, Croce C M. MicroRNAs in carcinogenesis [ J]. Cytogenet Genome Res, 2007,118 ( 2-4 ) :252-259.
9Lin P Y, Yu S L, Yang P C. MicroRNA in lung cancer [J]. Br J Cancer, 2010,103(8) :1144-1148.
10Duncavage E, Goodgame B, Sezhiyan A, et al. Use of microRNA expression levels to predict outcomes in resec- ted stage I non-small cell lung cancer [ J ]. J Thorac On- col, 2010,5(11) :1755-1763.
